Tocilizumab Calms Cytokine Storm and Lowers Risk of Dying by 45% in COVID-19 Patients on Ventilators
A study has found that critically ill COVID-19 patients who received tocilizumab, a drug that calms an overreacting immune system, were 45% less likely to die and more likely to leave the hospital or get off a ventilator one month after treatment, compared with those who did not receive the drug. More...15 Jul 2020
FDA-Approved Cholesterol-Lowering Drug Could Reduce SARS-CoV-2’s Ability to Reproduce or Even Make it Disappear
A FDA-approved cholesterol-lowering drug could stop SARS-CoV-2 from controlling our metabolism and potentially downgrade COVID-19’s danger level to that of a common cold. More...15 Jul 2020
EKF Diagnostics Launches Novel Molecular Transport Media for Dual COVID-19 and Influenza Sampling
EKF Diagnostics (Cardiff, UK) has added a new novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range. More...15 Jul 2020
COVID-19 Depends on ‘Master Regulators’ Inside Host Cells to Survive, Finds Study
Scientists have figured out how SARS-CoV-2 hijacks proteins in host cells that serve as master regulators of key cellular processes, allowing the virus to rewire the cell’s internal circuitry for promoting its own spread and survival. More...14 Jul 2020
COVID-19 Neurological Complications Could Cause Long Term Brain Damage in Recovered Patients, Warn Researchers
Researchers have warned that COVID-19 neurological complications, including delirium, brain inflammation, stroke, and nerve damage, could result in large scale brain damage in recovered patients over the long term. More...14 Jul 2020
Mount Sinai, Emergent, and ImmunoTek to Develop COVID-19 Hyperimmune Globulin Product
A COVID-19 hyperimmune globulin product will be evaluated in clinical trials, including a post-exposure prophylaxis (PEP) study on health care providers at high risk of COVID-19 infection and other high-risk populations. More...14 Jul 2020
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
New
Digital Radiographic System
OMNERA 300M
New
Computed Tomography System
Aquilion ONE / INSIGHT Edition
In Other News
Intranasal COVID-19 Vaccine Candidate Demonstrates Positive Results in Preclinical Studies
Pfizer and BioNTech Granted FDA Fast Track Designation for mRNA-Based COVID-19 Vaccines
Enzo Biochem Secures FDA Emergency Use Authorization for Proprietary Coronavirus Detection Test System
Scientists Identify Key Chemical Building Blocks for Antiviral Drug Against SARS-CoV-2
Gilead’s Remdesivir Reduces Risk of Death by 62% in Comparative Analysis of Phase 3 Data
Pfizer and BioNTech’s COVID-19 Vaccine Could Be Ready for Regulatory Approval by Year End
New SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit Enables Visual Detection of Coronavirus in 30 Minutes
Diazyme Receives FDA Emergency Use Authorization for New COVID-19 Antibody Test
Asthma Medicine Hailed as Effective Treatment for COVID-19
Artificial Intelligence Helps Identify T-cell Targets for Development of SARS-CoV-2 Vaccine
Synthetic Nanobodies Offer Potential for Development of Inhalable COVID-19 Drugs
EpiGentek Launches First-to-Market Kits to Detect SARS-CoV-2-Targeted Furin Activity and Screen for Inhibitors Against COVID-19
Triple Antibody Test for COVID-19 Provides Laboratory-Standard Results in Just Seven Minutes
Gilead Begins Testing Inhaled Version of Remdesivir for Treatment of COVID-19
China’s Sinovac Biotech Begins Phase 3 Trials of Coronavirus Vaccine Candidate in Brazil
Common Antihistamine Nasal Spray Identified as Potential Anti-COVID-19 Drug
Trivalent Influenza Vaccine Reduces Risk of Severe COVID-19, Especially Among High-Risk Groups, Finds Study
Oral Immunostimulant Could Improve Effectiveness of COVID-19 Vaccines by Increasing IgG Binding Antibody Responses
Innovative Nasal Powder Inhaler Blocks More than 99% of SARS-CoV-2 Viruses from Reaching Nasal Mucosa in Studies
New Rapid 45-Minute COVID-19 Test Ideal for Screening at Points of Risk
Moderna Completes Enrollment for Phase 2 Study of mRNA COVID-19 Vaccine
New ‘Pan-Viral’ Vaccine Aims to Protect Elderly from All Respiratory Viral Infections, Including COVID-19
Quantabio RT-qPCR Kit Given Expanded Role in CDC COVID-19 Testing Protocol
